US · MNDR · MEDICAL - CARE FACILITIES
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) intrinsic value and stock valuation
$0.95as of 2026-11-21 · Mkt cap 41.34K
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Mobile-health Network Solutions Class A Ordinary Shares DCF and intrinsic value
InvestorsCraft values MNDR with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from MNDR’s statements →
Mobile-health Network Solutions Class A Ordinary Shares Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2021–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $5.77M | $14M | $7.87M | $6.99M | $1.92M |
| Operating income | -$-2.68M | -$-15.55M | -$-2.41M | $140K | -$-470K |
| Net income | -$-2.55M | -$-15.6M | -$-2.35M | $90K | -$-460K |
| EPSd | -$-85M | -$-130M | -$-16.79M | $642.9K | -$-3.29M |
| Operating cash flow | -$-3.29M | -$-6.41M | -$-1.65M | $980K | -$-480K |
| Capital expenditure | -$-50K | -$-130K | -$-140K | -$-10K | -$0.00 |
| Free cash flow | -$-3.34M | -$-6.54M | -$-1.78M | $710K | -$-480K |
| Total assets | $3.49M | $7.95M | $3.44M | $7.73M | $690K |
| Total debt | $240K | $410K | $420K | $60K | $80K |
| Net debt | -$-570K | -$-6.3M | -$-1.8M | -$-7.3M | -$-40K |
| Total equity | $2.05M | $4.14M | -$-270K | $8.44M | -$-4.48M |
| Cash and short-term investments | $810K | $6.77M | $2.23M | $7.36M | $120K |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $5.77M | $14M | $7.87M | $6.99M | $1.92M |
| Cost of revenue | $6.43M | $11.4M | $6.79M | $5.05M | $2.12M |
| Gross profit | -$-660K | $2.54M | $1.09M | $1.94M | -$-200K |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $2.01M | $18.1M | $1.39M | $450K | $270K |
| Other expenses | $0.00 | $0.00 | $0.00 | $1.2M | $0.00 |
| Operating expenses | $2.01M | $18.1M | $1.39M | $1.65M | $270K |
| Cost and expenses | $8.45M | $29.5M | $11.1M | $6.79M | $2.39M |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation and amortization | $130K | $150K | $70K | $90K | $30K |
| Ebitda | -$-2.42M | -$-15.55M | -$-3.19M | $280K | -$-430K |
| Operating income | -$-2.68M | -$-15.55M | -$-2.41M | $140K | -$-470K |
| Total other income/expenses, net | $120K | -$-70K | $60K | $60K | $10K |
| Income before tax | -$-2.55M | -$-15.62M | -$-2.35M | $260K | -$-460K |
| Income tax expense | $0.00 | -$-20K | $0.00 | $170K | -$0.00 |
| Net income | -$-2.55M | -$-15.6M | -$-2.35M | $90K | -$-460K |
| Weighted average shares outstanding | $30K | $120K | $140K | $140K | $140K |
| Weighted average diluted shares outstanding | $30K | $120K | $140K | $140K | $140K |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $810K | $6.77M | $2.23M | $7.36M | $120K |
| Net receivables | $370K | $180K | $260K | $200K | $250K |
| Inventory | $80K | $160K | $150K | $50K | $70K |
| Total current assets | $1.4M | $7.29M | $2.72M | $7.57M | $460K |
| Property, plant and equipment, net | $240K | $590K | $420K | $70K | $100K |
| Goodwill and intangible assets | $1.85M | $20K | $70K | $120K | $180K |
| Long-term investments | $0.00 | $40K | $60K | $0.00 | $0.00 |
| Total non-current assets | $2.09M | $660K | $720K | $150K | $230K |
| Total assets | $3.49M | $7.95M | $3.44M | $7.73M | $690K |
| Accounts payable | $680K | $1.23M | $670K | $400K | $260K |
| Short-term debt | $130K | $280K | $180K | $40K | $30K |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $100K | $0.00 |
| Total current liabilities | $1.33M | $3.16M | $2.5M | $1.27M | $490K |
| Long-term debt | $110K | $140K | $240K | $20K | $50K |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $110K | $650K | $1.31M | $1.05M | $6.3M |
| Capital lease obligations | $0.00 | $380K | $400K | $60K | $80K |
| Total liabilities | $1.44M | $3.81M | $3.81M | $2.32M | $5.18M |
| Common stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained earnings | -$-22.09M | -$-24.76M | -$-9.15M | -$-5.94M | -$-4.49M |
| Accumulated other comprehensive income (loss) | $460K | $430K | $290K | -$-110K | $10K |
| Total equity | $2.05M | $4.14M | -$-270K | $8.44M | -$-4.48M |
| Total investments | $0.00 | $100K | $60K | $20K | $0.00 |
| Total debt | $240K | $410K | $420K | $60K | $80K |
| Net debt | -$-570K | -$-6.3M | -$-1.8M | -$-7.3M | -$-40K |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-2.55M | -$-15.6M | -$-2.35M | $90K | -$-460K |
| Depreciation and amortization | $130K | $110K | $90K | $90K | $30K |
| Stock-based compensation | $0.00 | $9.12M | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-1.45M | -$-260K | $460K | $550K | -$-80K |
| Accounts receivable | -$0.00 | -$-40K | -$0.00 | $90K | -$-80K |
| Inventory | $60K | -$-20K | -$-70K | $20K | -$-10K |
| Accounts payable | -$-600K | $310K | $550K | $220K | $30K |
| Net cash provided by operating activities | -$-3.29M | -$-6.41M | -$-2.25M | $980K | -$-480K |
| Investments in property, plant and equipment | -$-1.84M | -$-130K | -$-140K | -$-10K | -$0.00 |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-1.84M | -$-130K | -$-190K | -$-20K | -$0.00 |
| Common stock issued | $740K | $10.9M | $840K | $9.71M | $0.00 |
| Common stock repurchased | $0.00 | $0.00 | -$-6.6M | $0.00 | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $720K | $10.9M | -$-5.8M | $9.23M | $390K |
| Net change in cash | -$-4.14M | $4.48M | -$-8.02M | $10.1M | $120K |
| Cash at end of period | $810K | $6.71M | $2.23M | $10.2M | $120K |
| Operating cash flow | -$-3.29M | -$-6.41M | -$-1.65M | $980K | -$-480K |
| Capital expenditure | -$-50K | -$-130K | -$-140K | -$-10K | -$0.00 |
| Free cash flow | -$-3.34M | -$-6.54M | -$-1.78M | $710K | -$-480K |
Line items
Line items
Line items
About Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions (MNDR) functions as an investment holding company focused on delivering telehealth services across Singapore. Its business operations are primarily divided into two main segments: Telemedicine and Ancillary Services, and the sale of pharmaceutical products and medical devices. A cornerstone of its offerings is the MaNaDr platform, designed as a comprehensive digital healthcare ecosystem. This platform seamlessly connects patients with healthcare providers, offering a wide array of services and products that are conveniently accessible via both a mobile application and a dedicated website. Beyond its digital platform, MNDR delivers extensive primary care services. These encompass routine medical consultations, the diagnosis and management of both acute and chronic illnesses in adult and pediatric patients, immunizations, and various health screenings (e.g., for work permits and pre-employment checks). Additionally, the company provides specialized care for children and the elderly, alongside performing minor surgical procedures. Further diversifying its revenue streams, the company maintains an online e-commerce platform for health and wellness products. It also engages in the wholesale supply of pharmaceuticals to clinics. A key corporate offering is MaNaCare, a specialized platform delivering a suite of corporate healthcare and wellness solutions. These include access to general practitioners, specialists, and allied healthcare professionals; remote consultations; physical clinic visits; on-site health assessments; and an online community forum and marketplace, complemented by various wellness programs tailored for businesses. MNDR is also involved in the development of IT systems for mobile and web-based applications. Its physical presence includes operating pharmacies, medical clinics, and drug stores. The company extends its services to include beauty and personal care, alongside a broader spectrum of general medical and health offerings. Established in 2009, Mobile-health Network Solutions is headquartered in Singapore.
- CEO
- Tung Yeng Siaw
- Employees
- 73
- Beta
- -0.94
Explore
Frequently asked questions
What is the intrinsic value of Mobile-health Network Solutions Class A Ordinary Shares (MNDR)?
InvestorsCraft does not currently publish an intrinsic value for MNDR. How the IC value is calculated.
Is MNDR undervalued?
InvestorsCraft does not publish an undervaluation signal for MNDR at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.